Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotyping malignant pleural effusions.

Current opinion in pulmonary medicine - 1 Jul 2016

Lui Macy M S, Fitzgerald Deirdre B, Lee Y C Gary

Abstract excerpt

PURPOSE OF REVIEW: Patients with malignant pleural effusions (MPEs) are heterogenous in their disease course, symptom severity, responses to cancer therapies, fluid recurrence rates, and thus need for definitive fluid control measures. To tailor the most appropriate treatment for individual patients, clinicians need to 'phenotype' the patients and predict their clinical course. This review highlights the recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Health Status Indicators
Share to Phenotype
Share to Pleural Effusion, Malignant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Source

Identifiers

PMID: 27055073
DOI: 10.1097/MCP.0000000000000267

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotyping malignant pleural effusions.PMID 27055073Read ↗

Current best practice in the evaluation and management of malignant pleural effusions.Semantic proximity Read ↗

Diagnostic molecular biomarkers for malignant pleural effusions.Semantic proximity Read ↗

Clinical identification of malignant pleural effusionsSemantic proximity Read ↗

Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single-Cell Transcriptomics.Semantic proximity Read ↗

Patient-derived organoids from malignant pleural effusion to explore for alternative therapies in thoracic tumorsSemantic proximity Read ↗

Prognosticating Mesothelioma Using Predictive AnalyticsSemantic proximity Read ↗

Re-Evaluating Breast Malignant Pleural Effusion: Toward Evidence-Based, Precision-Aligned Care with OrganoidsSemantic proximity Read ↗

Re-Evaluating Breast Malignant Pleural Effusion: Toward Evidence-Based, Precision-Aligned Care with OrganoidsSemantic proximity Read ↗

Diagnosis and Treatment of Pleural EffusionSemantic proximity Read ↗

Management of malignant pleural mesothelioma.Semantic proximity Read ↗

The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.Semantic proximity Read ↗

Identification of Distinct Clinical Phenotypes in Chemotherapy-Induced Neutropenic Fever Patients and Their Associated Predictors of MortalitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.